APA (7th ed.) Citation

Zarouchlioti, C., Sanchez-Pintado, B., Hafford Tear, N. J., Klein, P., Liskova, P., Dulla, K., . . . Davidson, A. E. (2018). Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity. American journal of human genetics, 102(4), 528-539. https://doi.org/10.1016/j.ajhg.2018.02.010

Chicago Style (17th ed.) Citation

Zarouchlioti, Christina, et al. "Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity." American Journal of Human Genetics 102, no. 4 (2018): 528-539. https://doi.org/10.1016/j.ajhg.2018.02.010.

MLA (9th ed.) Citation

Zarouchlioti, Christina, et al. "Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity." American Journal of Human Genetics, vol. 102, no. 4, 2018, pp. 528-539, https://doi.org/10.1016/j.ajhg.2018.02.010.